- Home
- LFCR vs SENS Comparison
LFCR vs SENS Comparison
Compare LFCR & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFCR | SENS |
|---|---|---|
| Founded | 1986 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.8M | 308.5M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LFCR | SENS |
|---|---|---|
| Price | $6.78 | $5.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | N/A | ★ $22.70 |
| AVG Volume (30 Days) | 100.5K | ★ 532.6K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $557,559,000.00 | $16,389,000.00 |
| Revenue This Year | $2.80 | $70.20 |
| Revenue Next Year | $11.51 | $59.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 6.36 | ★ 19.85 |
| 52 Week Low | $4.76 | $0.41 |
| 52 Week High | $8.98 | $8.75 |
Technical Indicators
Market Signals| Indicator | LFCR | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 30.53 |
| Support Level | $6.60 | $5.46 |
| Resistance Level | $7.03 | $8.55 |
| Average True Range (ATR) | 0.29 | 0.49 |
| MACD | -0.01 | -0.28 |
| Stochastic Oscillator | 32.65 | 3.53 |
Price Performance
Historical ComparisonAbout LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.